PredictImmune Gains CE-IVD Mark for IBD Test

Dec 11, 2018

|

NEW YORK (GenomeWeb) – PredictImmune has obtained a CE-IVD mark for its debut test for inflammatory bowel disease, the company said today.

By achieving certification for the test, called PredictSure IBD, the Cambridge, UK-based firm can sell it for clinical use across Europe and other geographies that recognize the designation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Snakes and Bats and People

An initial analysis suggests the novel coronavirus from Wuhan that is sickening people might come from snakes, a team of virologists writes at the Conversation.

Coyote Match in Chicago

DNA testing confirms captured Chicago coyote same as the one that bit a boy near a nature museum, the Chicago Tribune reports.

Viruses on Ice

An analysis of Tibetan ice cores uncovers more than two dozen previously unknown virus groups, LiveScience reports.

Nature Papers Examine Ancient Human DNA From Africa, Present Approach to Study Microbiota

In Nature this week: genomic analysis of four children buried in Cameroon approximately 3,000 and 8,000 years ago, and more.

Featured White Papers

A Machine-Learning Framework for Accurate Classification and Quantification of Oncogenic Variants Using the QuantideX NGS DNA Hotspot 21 Kit

BCR-ABL1 Minor Breakpoint (e1a2) Monitoring Using an Analytically Validated Multiplex Assay

Modifications to RNA Isolation Protocols Meet Requirements for Modern CML Monitoring of BCR-ABL1 Transcript Levels

Analytical Validation of the QuantideX NGS DNA Hotspot 21 Kit, A Diagnostic NGS System for the Detection of Actionable Mutations in FFPE Tumors

Jan

28

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb

05

Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb

25

Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts.

Feb

26

Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Menu

PredictImmune Gains CE-IVD Mark for IBD Test

To read the full story....

Breaking News

RNAssist Licenses Biomolecule Stabilization Tech to QCMD

Genomes of Healthy Elderly Show Fewer Disease-Linked Variants

Evotec, Indivumed to Collaborate on Non-Small Cell Lung Cancer Drug Discovery

Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

LifeOmic, IU's Komen Tissue Bank Integrate Platforms to Further Breast Cancer Research

Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent

The Scan

Snakes and Bats and People

Coyote Match in Chicago

Viruses on Ice

Nature Papers Examine Ancient Human DNA From Africa, Present Approach to Study Microbiota

Featured White Papers

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Development of a Novel Multiplex Assay: A Partnership Case Study

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

What's Popular?

Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement

OraSure's DNA Genotek Gets FDA Clearance for Sample Collection Kits

FNIH Team Selects Cancer Biomarkers in Phase I of Liquid Biopsy Reference Standards Project

Myriad Genetics Files for FDA Approval of BRACAnalysis CDx for Lynparza in Prostate Cancer

Heart Transplant Monitoring Test From TAI Diagnostics Validated in New Study

Sponsorships